NEW YORK – PlumCare and Fabric Genomics said Thursday that they have partnered to integrate the Fabric AI platform with PlumCare’s FirstSteps newborn genome screening program in Greece.
Financial details of the deal were not disclosed.
With the goal to screen every newborn in Greece by whole-genome sequencing within the next five years, the FirstSteps program will utilize the Fabric AI platform to offer rapid, accurate clinical genomic variant interpretation for WGS data collected, the partners said.
Fabric said it will also customize its platform to the specific needs required in the FirstSteps program.
"Bringing the Fabric AI platform to support and speed up our variant interpretation process will enhance the overall performance of the FirstSteps program and help improve the lives of patients with rare genetic diseases in Greece and around the world," Dimitris Thanos, member of the Academy of Athens and vice chairman of the scientific advisory board of FirstSteps, said in a statement.
Previously, Fabric has forged partnerships with medical institutions such as Rady Children’s Institute for Genomic Medicine and the Broad Institute of MIT and Harvard to offer affordable clinical whole-genome analysis leveraging its AI platform.